Get Flat 15% Discount on ED Drugs for orders value $70 or more
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Sun Pharma > September 16, 2005

      Sun Pharma buys Valeant's Ohio facility


      After having acquired Valeant Pharma's manufacturing unit in Hungary last month, the Mumbai-based drug major Sun Pharma has signed an agreement to buy the company's manufacturing facility at Ohio as well. The cost of acquisition has not been disclosed in both cases.The company has been scouting around for an acquisition in the US and a company official said that the search is still on, unaltered by the recent acquisition of Valeant's plant. Sun Pharma was waiting for the right valuation, the official said. The company had issued a $350-million FCCB late last year, primarily to support a major acquisition in the US.

      Sun Pharma's Chairman and Managing Director, Dilip Shanghvi, said in a statement that the recent Valeant acquisition would help accelerate filings for the US generic market. It would also address opportunities in liquids and semi-solids like creams and ointments, he said, where Sun Pharma has products under development.

      Meanwhile, Timothy C. Tyson, Valeant's President and Chief Executive Officer, said: "The execution of our manufacturing improvement plan continues to move forward aggressively. We expect to complete more facility divestments in the near future and remain confident in our ability to reduce the network to four manufacturing sites by the end of 2006." Valeant expects to rationalise its 15 manufacturing facilities down to four by 2006.

      Other facilities: Sun Pharma's overseas subsidiary, the Detroit-based Caraco Pharma Labs also has a manufacturing facility. Caraco's facility manufactures a variety of tablets, the official said, besides handling marketing of the medicines, Sun's representative said. Currently, Sun Pharma holds about 69 per cent equity in Caraco.

      Last month, Sun Pharma had acquired Valeant's raw materials and dosage-form manufacturing operations in Hungary, marking Sun's foray into Europe. Sun Pharma's last major overseas acquisition was in 1997, when the company had acquired about 30 per cent equity in Caraco, a generic company that manufactures and markets generic drugs and private label prescription drugs.

      September 16, 2005


      Share this Article!

    Back to top^